company background image
SCTL logo

Societal CDMO NasdaqCM:SCTL 株式レポート

最終価格

US$1.10

時価総額

US$116.3m

7D

0%

1Y

4.8%

更新

08 Apr, 2024

データ

会社財務 +

Societal CDMO, Inc.

NasdaqCM:SCTL 株式レポート

時価総額:US$116.3m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

SCTL 株式概要

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally.

SCTL fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Societal CDMO, Inc. 競合他社

価格と性能

Summary of all time highs, changes and price drops for Societal CDMO
Historical stock prices
Current Share PriceUS$1.10
52 Week HighUS$1.28
52 Week LowUS$0.26
Beta1.52
1 Month Change1.85%
3 Month Change181.33%
1 Year Change4.76%
3 Year Change-65.52%
5 Year Change-86.89%
Change since IPO-86.75%

最新ニュース

Recent updates

Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Feb 10
Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?

Feb 02
Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?

Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?

Dec 23
Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?

Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?

May 31
Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?

Societal CDMO signs two CDMO service agreements

Oct 20

Societal stock soars 20% on signing 2 manufacturing contracts

Sep 07

Societal CDMO estimates to receive up to $50M on real estates' sales

Aug 16

Societal CDMO, Lannett amend license and supply deal

Jul 12

These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively

Apr 29
These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively

Is Recro Pharma (NASDAQ:REPH) A Risky Investment?

Jan 06
Is Recro Pharma (NASDAQ:REPH) A Risky Investment?

Recro Pharma jumps 15% on Q1 result estimates beat

May 07

Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?

Feb 15
Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?

株主還元

SCTLUS PharmaceuticalsUS 市場
7D0%-0.5%1.6%
1Y4.8%16.6%21.5%

業界別リターン: SCTL過去 1 年間で18.2 % の収益を上げたUS Pharmaceuticals業界を下回りました。

リターン対市場: SCTLは、過去 1 年間で21.8 % のリターンを上げたUS市場を下回りました。

価格変動

Is SCTL's price volatile compared to industry and market?
SCTL volatility
SCTL Average Weekly Movement39.2%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement5.7%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market2.9%

安定した株価: SCTLの株価は過去 3 か月間にわたって変動しています。

時間の経過による変動: SCTLの 週次ボラティリティ は、過去 1 年間で23%から39%に増加しました。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
2007258J. Enloewww.societalcdmo.com

Societal CDMO, Inc. 基礎のまとめ

Societal CDMO の収益と売上を時価総額と比較するとどうか。
SCTL 基礎統計学
時価総額US$116.26m
収益(TTM)-US$13.27m
売上高(TTM)US$94.64m

1.2x

P/Sレシオ

-8.8x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
SCTL 損益計算書(TTM)
収益US$94.64m
売上原価US$76.50m
売上総利益US$18.14m
その他の費用US$31.41m
収益-US$13.27m

直近の収益報告

Dec 31, 2023

次回決算日

該当なし

一株当たり利益(EPS)-0.13
グロス・マージン19.17%
純利益率-14.03%
有利子負債/自己資本比率63.2%

SCTL の長期的なパフォーマンスは?

過去の実績と比較を見る